The first Cell and Gene Therapy Regulatory Report from Citeline and the International Society for Cell & Gene Therapy (ISCT) provides a global overview of the cell and gene therapy landscape, including pipeline, late-stage (Phase III and pre-registration), and approved products. It covers cell, genetically modified cell, and gene therapies.
